Report on an investigational mitochondrial therapy progressing after a few compassionate-use pediatric cases and supporting translational data plus regulatory alignment.
Key Takeaways
- Clinical-stage biopharma company BPGbio has revealed new findings supporting BPM31510
- Is the FDA beginning to rethink how it evaluates treatments for devastating ultra-rare diseases
- CoQ10 has become almost synonymous with healthy aging